Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2852-2858, November 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shepard, J. S.
Right arrow Articles by Sorenson, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shepard, J. S.
Right arrow Articles by Sorenson, G. D.

Alterations of Karyotype and Oncogenicity in Mouse Myeloma MOPC-315 and 5-Bromodeoxyuridine-resistant Cell Lines1

June S. Shepard, Olive S. Pettengill, Doris H. Wurster-Hill and George D. Sorenson2

Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire 03755

Spontaneous loss of oncogenicity has been found to occur in cultured mouse myeloma cells. A cell line SLU-J27, established from mouse myeloma MOPC-315, was shown to be quite similar in karyotype and tumorigenicity to the tumor of origin. Both contained two markers previously shown to be consistently present in another myeloma, MOPC-21, and in five derived cell lines. These were: a No. 12 chromosome with an extra terminal band and a partially deleted No. 15 chromosome. The SLU-J27 cell line contained two populations that differed in having one or two X chromosomes. When this cell line was inoculated into mice, the resultant tumors were all derivatives of the "2X" population. With time in culture the 2X population gained two new markers and the oncogenicity of the cell line decreased. 5-Bromodeoxyuridineresistant lines derived from SLU-J27 had only the 2X modal karyotype. All centric fusions were between homologs, with one possible exception, suggesting homolog association.

1 Supported in part by Grants CA 13595, CA 13625, and HD 03298.

2 To whom reprint requests should be addressed, at Department of Pathology, Dartmouth Medical School, Hanover, N. H. 03755.

Received 3/ 7/74. Accepted 6/26/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.